Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516927 · ClinicalTrials.gov registry record
The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
A clinical trial, sponsored by Freenome Holdings.
- Completed
- Registry status
- 788
- Enrollment target
NCT05516927 is a clinical trial that has completed, run by Freenome Holdings. The registered enrollment target is 788 participants.
The verdict
NCT05516927 has completed, sponsored by Freenome Holdings.
- COMPLETED
- Registry status
- 788 participants
- Enrollment target
Study Summary
This protocol is a prospective, case-control multi-center diagnostic study to assess the sensitivity and specificity of blood-based screening tests for the early detection of multiple cancers.
Interventions
- DIAGNOSTIC_TEST Freenome Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 788 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2024-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516927
The ClinicalTrials.gov registry entry for NCT05516927 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 788 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Freenome Holdings, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Freenome Test is the first listed.
NCT05516927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05516927 about?
NCT05516927 is a clinical study titled "The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening". This protocol is a prospective, case-control multi-center diagnostic study to assess the sensitivity and specificity of blood-based screening tests for the early detection of multiple cancers.
What is the current status of trial NCT05516927?
This trial is currently completed. The enrollment target is 788 participants. The study started on 2022-09-06. Estimated completion is 2024-05-02.
What interventions are being tested in trial NCT05516927?
The interventions under investigation include: Freenome Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05516927?
This trial is sponsored by Freenome Holdings, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.